Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Equity Ratio (2022 - 2025)

Historic Equity Ratio for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 0.77.

  • bioAffinity Technologies' Equity Ratio rose 6185.62% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year increase of 6185.62%. This contributed to the annual value of 0.4 for FY2024, which is 3235.6% down from last year.
  • Per bioAffinity Technologies' latest filing, its Equity Ratio stood at 0.77 for Q3 2025, which was up 6185.62% from 0.45 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Equity Ratio ranged from a high of 0.92 in Q1 2023 and a low of 0.45 during Q2 2025
  • For the 4-year period, bioAffinity Technologies' Equity Ratio averaged around 0.58, with its median value being 0.65 (2024).
  • Over the last 5 years, bioAffinity Technologies' Equity Ratio had its largest YoY gain of 6185.62% in 2025, and its largest YoY loss of 18717.37% in 2025.
  • Over the past 4 years, bioAffinity Technologies' Equity Ratio (Quarter) stood at 0.91 in 2022, then crashed by 34.86% to 0.59 in 2023, then tumbled by 32.36% to 0.4 in 2024, then surged by 93.0% to 0.77 in 2025.
  • Its Equity Ratio was 0.77 in Q3 2025, compared to 0.45 in Q2 2025 and 0.26 in Q1 2025.